-+ 0.00%
-+ 0.00%
-+ 0.00%

ORIC PHARMACEUTICALS INC : STIFEL RESUMES COVERAGE WITH BUY RATING; TARGET PRICE $14

Reuters·06/12/2026 10:55:30

Please log in to view news